MF, Rosano G, Ruschitzka F, Volterrani M, Voors AA, Filippatos G, Coats AJ. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019;21: 1169–1186. 4. European Society of Cardiology (ESC). Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. 21 April 2020. https://www.escardio.org/Education/COVID-19and-Cardiology/ESC-COVID-19-Guidance (27 May 2020). 5. Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomon SD, Metra M. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail 2020;22: 957–966. 6. De Filippo O, D’Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A, Secco GG, Campo G, Gallone G, Verardi R, Gaido L, Iannaccone M, Galvani M, Ugo F, Barbero U, Infantino V, Olivotti L, Mennuni M, Gili S, Infusino F, Vercellino M, Zucchetti O, Casella G, Giammaria M, Boccuzzi G, Tolomeo P, Doronzo B, Senatore G, Grosso Marra W, Rognoni A, Trabattoni D, Franchin L, Borin A, Bruno F, Galluzzo A, Gambino A, Nicolino A, Truffa Giachet A, Sardella G, Fedele F, Monticone S, Montefusco A, Omedè P, Pennone M, Patti G, Mancone M, De Ferrari GM. Reduced rate of hospital admissions for ACS during Covid19 outbreak in Northern Italy. N Engl J Med 2020;383:88–89. 7. Piccolo R, Bruzzese D, Mauro C, Aloia A, Baldi C, Boccalatte M, Bottiglieri G, Briguori C, Caiazzo G, Calabrò P, Cappelli-Bigazzi M, de Simone C, di Lorenzo E, Golino P, Monda V, Perrotta R, Quaranta G, Russolillo E, Scherillo M, Tesorio T, Tuccillo B, Valva G, Villari B, Tarantini G, Varricchio A, Esposito G. Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the COVID-19 outbreak. Circulation 2020;141: 2035–2037. 8. Fraiche AM, Eapen ZJ, McClellan MB. Moving beyond the walls of the clinic: opportunities and challenges to the future of telehealth in heart failure. JACC Heart Fail 2017;5:297–304. 9. Gorodeski EZ, Goyal P, Cox ZL, Thibodeau JT, Reay RE, Rasmusson K, Rogers JG, Starling RC. Virtual visits for care of patients with heart failure in the era of COVID-19: a statement from the Heart Failure Society of America. J Card Fail 2020;26:448–456. 10. Cleland JG, Clark RA, Pellicori P, Inglis SC. Caring for people with heart failure and many other medical problems through and beyond the COVID-19 pandemic; the advantages of universalaccess to home telemonitoring. Eur J Heart Fail 2020;22:995–998.
[1]
S. Solomon,et al.
COVID‐19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease
,
2020,
European journal of heart failure.
[2]
R. Clark,et al.
Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic: the advantages of universal access to home telemonitoring
,
2020,
European journal of heart failure.
[3]
F. Fedele,et al.
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy
,
2020,
The New England journal of medicine.
[4]
J. Rogers,et al.
Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America
,
2020,
Journal of Cardiac Failure.
[5]
D. Morrow,et al.
COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery
,
2020,
Journal of the American College of Cardiology.
[6]
F. Ruschitzka,et al.
COVID-19 Illness and Heart Failure
,
2020,
JACC: Heart Failure.
[7]
Karl Swedberg,et al.
Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure
,
2007,
Circulation.
[8]
H. Tsutsui.
[Candesartan in heart failure: assessment of reduction in mortality and morbidity].
,
2007,
Nihon rinsho. Japanese journal of clinical medicine.
[9]
G. Moyle.
Research Letters
,
2022
.